Optinate 5 mg Filmdragerad tablett

Land: Sverige

Språk: svenska

Källa: Läkemedelsverket (Medical Products Agency)

Köp det nu

Bipacksedel Bipacksedel (PIL)
22-04-2018
Produktens egenskaper Produktens egenskaper (SPC)
22-04-2018

Aktiva substanser:

risedronatnatrium

Tillgänglig från:

Theramex Ireland Limited

ATC-kod:

M05BA07

INN (International namn):

risedronate

Dos:

5 mg

Läkemedelsform:

Filmdragerad tablett

Sammansättning:

laktosmonohydrat Hjälpämne; risedronatnatrium 5 mg Aktiv substans

Klass:

Apotek

Receptbelagda typ:

Receptbelagt

Terapiområde:

Risedronsyra

Produktsammanfattning:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 84 tabletter; Blister, 98 tabletter; Blister, 140 tabletter (sjukhusförpackning); Blister, 20 x 1 tablett (endos och sjukhusförpackning)

Bemyndigande status:

Godkänd

Tillstånd datum:

1999-10-07

Bipacksedel

                                Page 1 of 6
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
OPTINATE 5 MG FILM-COATED TABLETS
risedronate sodium
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Optinate is and what it is used for
2.
What you need to know before you take Optinate
3.
How to take Optinate
4.
Possible side effects
5.
How to store Optinate
6.
Contents of the pack and other information
1.
WHAT OPTINATE IS AND WHAT IT IS USED FOR
WHAT OPTINATE IS
Optinate belongs to a group of non-hormonal medicines called
bisphosphonates which are used to treat
bone diseases. It works directly on your bones to make them stronger
and therefore less likely to
break.
Bone is a living tissue. Old bone is constantly removed from your
skeleton and replaced with new
bone.
Postmenopausal osteoporosis is a condition occurring in women after
the menopause where the bones
become weaker, more fragile and more likely to break after a fall or
strain.
Osteoporosis is more likely to occur in women who have reached the
menopause early and also in
patients treated long-term with steroids.
The spine, hip and wrist are the most likely bones to break, although
this can happen to any bone in
your body. Osteoporosis –related fractures can also cause back pain,
height loss and a curved back.
Many patients with osteoporosis have no symptoms and you may not even
have known that you had it.
WHAT OPTINATE IS USED FOR
The treatment of osteoporosis

in postmenopausal women
The prevention of osteoporosis

in women with an increased risk of osteoporosi
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel engelska 17-08-2022
Produktens egenskaper Produktens egenskaper engelska 18-10-2018